Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Oduyebo, O. O."'
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Jan2024, Vol. 25 Issue 1, p86-94, 9p
Autor:
Iregbu, K. C., Oduyebo, O. O., Taiwo, S. S., Nwajiobi-Princewill, P. I., Oshun, P. O., Nwafia, I. N., Elikwu, C. J., Manga, M. M., Oboro, I. L., Kudayah, I. O.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Oct2023, Vol. 24 Issue 4, p314-338, 25p
Autor:
George, O. T., Oduyebo, O. O.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Apr2022, Vol. 23 Issue 2, p174-181, 8p
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Apr2022, Vol. 23 Issue 2, p131-140, 10p
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Oct2021, Vol. 22 Issue 4, p498-503, 6p
Autor:
Oshun, P. O., Roberts, A. A., Osuagwu, C. S., Akintan, P. E., Fajolu, I. B., Ola-Bello, O. I., Odukoya, O. O., Akodu, B., Okunowo, A. A., Versporten, A., Pauwels, I., Goosens, H., Busari, A. A., Olusanya, A. W., Nwaiwu, O., Temiye, E. O., Osibogun, A. O., Bode, C. O., Oduyebo, O. O.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Apr2021, Vol. 22 Issue 2, p260-272, 13p
Autor:
Manga, M. M., Ibrahim, M., Hassan, U. M., Joseph, R. H., Muhammad, A. S., Danimo, M. A., Ganiyu, O., Versporten, A., Oduyebo, O. O.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Apr2021, Vol. 22 Issue 2, p273-278, 6p
Autor:
Umeokonkwo, C. D., Oduyebo, O. O., Fadeyi, A., Versporten, A., Ola-Bello, O. I., Fowotade, A., Elikwu, C. J., Pauwels, I., Kehinde, A., Ekuma, A., Goossens, H., Adedosu, A. N., Nwafia, I. N., Nwajiobi-Princewill, P., Ogunsola, F. T., Olayinka, A. T., Iregbu, K. C.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Apr2021, Vol. 22 Issue 2, p252-259, 8p
Autor:
Egwuatu, C. C., Ogunsola, F. T., Iwuafor, A. A., Akujobi, C. N., Egwuatu, T. O., Nnachi, A. U., Oduyebo, O. O.
Publikováno v:
African Journal of Infectious Diseases; Vol 11, No 1 (2017); 18-25
Background: The daily use of Trimethoprim-Sulfamethoxazole (TMP-SMX) prophylaxis reduces morbidity and mortality among patients infected with human immunodeficiency virus (HIV) but its impact on increasing antimicrobial resistance rates has been of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::ce274e3ec3e72cd2cdec391fef74bde6
https://www.ajol.info/index.php/ajid/article/view/156806
https://www.ajol.info/index.php/ajid/article/view/156806
Autor:
Iregbu, K. C., Osuagwu, C. S., Umeokonkwo, C. D., Fowotade, A. A., Ola-Bello, O. I., Nwajiobi-Princewill, P. I., Taiwo, S. S., Olayinka, A. T., Oduyebo, O. O.
Publikováno v:
African Journal of Clinical & Experimental Microbiology; Jan2020, Vol. 21 Issue 1, p53-59, 7p